| ANNOVIS BIO INC. DL-,0001 |
| USA |
| Gesundheit |
| US03615A1088 / A2PNH2 |
| 07X (Frankfurt) |
| FRA:07X, ETR:07X, 07X:GR |
| - |
| https://www.annovisbio.co.. |
|
Annovis Bio, Inc. is a biopharmaceutical company committed to developing novel therapeutic solutions for neurodegenerative diseases. At the core of its operations is the design of drugs aiming to inhibit neurotoxic protein buildup associated with con..
>Volltext.. |
| 52.08 Mio. EUR |
| 35.45 Mio. EUR |
| - |
| -25.73 Mio. EUR |
| -25 Mio. EUR |
| -1.21 EUR |
| - |
| 16.92 Mio. EUR |
| -22.19 Mio. EUR |
| 5.37 |
| - |
| -3.42% |
| - |
| - |
| - |
| - |
| ANNOVIS BIO |
| 05.04.26 |
|